Cognitive control as a transdiagnostic mechanism of action in psychedelic effects.

Cogn Affect Behav Neurosci November 11, 2025 DOI: 10.3758/s13415-025-01362-5 (opens in new tab) via PubMed

Summary

AI-generated from the abstract

Cognitive control may serve as a transdiagnostic mechanism through which psychedelics exert their effects, suggesting that improvements in cognitive control processes could underlie therapeutic benefits across various psychiatric conditions.

Study at a glance

Characteristics	Theoretical or philosophical paper Peer reviewed
Key finding	Proposes that cognitive control is a transdiagnostic mechanism through which psychedelics exert therapeutic effects.

Abstract

Cognitive control as a transdiagnostic mechanism of action in psychedelic effects.

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective Frontiers in Psychiatry December 17, 2021 66 citations via OpenAlex
A complex systems perspective on psychedelic brain action. Trends Cogn Sci February 3, 2023 76 citations via PubMed
Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience bioRxiv (Cold Spring Harbor Laboratory) May 12, 2023 17 citations via OpenAlex
Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach Neurobiology of Learning and Memory May 25, 2021 49 citations via OpenAlex
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? Frontiers in Psychiatry July 19, 2021 95 citations via OpenAlex

Comments

No comments yet.

Summary

Study at a glance

Abstract

Related reading

Comments